Skip to Content

TEVA 5346 (Methylphenidate Hydrochloride Extended-Release (LA) 20 mg)

Pill with imprint TEVA 5346 is White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 20 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5346

Methylphenidate hydrochloride extended-release (LA) 20 mg TEVA 5346

Methylphenidate Hydrochloride Extended-Release (LA)

Imprint
TEVA 5346
Strength
20 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5346

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.